RECORD // Company

Fortress Biotech, Inc.

Formerly: Fortress Biotech, Inc.; CORONADO BIOSCIENCES INC

Built 2026-11-22T03:17:07Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Records under a former name (1)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (2)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Fortress Biotech · Breach states · exact name match to 'Fortress Biotech, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • FORTRESS BIOTECH, INC. · Ny corps · same registered legal name as 'Fortress Biotech, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001104659-26-126531

ItemValuePeriodFormFiledAccessionReport
Revenue$19,159,0003 months ended 2026-09-3010-Q2026-11-130001104659-26-1265312026-11-22 03:17 UTCReport an error
Net income (loss)$-5,845,0003 months ended 2026-09-3010-Q2026-11-130001104659-26-1265312026-11-22 03:17 UTCReport an error
Interest expense$2,498,0003 months ended 2026-09-3010-Q2026-11-130001104659-26-1265312026-11-22 03:17 UTCReport an error
Cash and cash equivalents$152,186,000at 2026-09-3010-Q2026-11-130001104659-26-1265312026-11-22 03:17 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001429260
Ticker
FBIO
EIN
205157386
CUSIP
34960Q307
Record ID
sx:sec:0001429260

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

35 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-19SEC EDGAR company profile2026-11-22 03:17 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-19SEC EDGAR company profile2026-11-22 03:17 UTCReport an error
State of incorporationDE2026-11-19SEC EDGAR company profile2026-11-22 03:17 UTCReport an error
Fiscal year end (MMDD)12312026-11-19SEC EDGAR company profile2026-11-22 03:17 UTCReport an error
Business address1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 331542026-11-19SEC EDGAR company profile2026-11-22 03:17 UTCReport an error
ExchangesNasdaq, Nasdaq2026-11-19SEC EDGAR company profile2026-11-22 03:17 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$63,262,0002025-12-3110-K, XBRL Revenues2026-11-22 03:17 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$6,815,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 03:17 UTCReport an error
Total assets (at 2025-12-31)$185,548,0002025-12-3110-K, XBRL Assets2026-11-22 03:17 UTCReport an error
Stockholders' equity (at 2025-12-31)$49,873,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 03:17 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$79,381,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:17 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-65,777,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:17 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31)$02024-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 03:17 UTCReport an error
Long-term debt (at 2025-12-31)$52,417,0002025-12-3110-K, XBRL LongTermDebt2026-11-22 03:17 UTCReport an error
Operating lease liabilities (at 2025-12-31)$14,799,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 03:17 UTCReport an error
Form D total offering amount (D filed 2018-03-13)$30,000,0002018-03-13D2026-11-22 03:17 UTCReport an error
Form D total amount sold (D filed 2018-03-13)$6,517,0002018-03-13D2026-11-22 03:17 UTCReport an error
Form D industry groupBiotechnology2018-03-13D2026-11-22 03:17 UTCReport an error
Form D revenue rangeDecline to Disclose2018-03-13D2026-11-22 03:17 UTCReport an error
Form D date of first sale2018-02-282018-03-13D2026-11-22 03:17 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-13)On November 13, 2026, Fortress Biotech, Inc. issued a press release to provide a corporate update and to announce its financial results for the quarter ended September 30, 2026. A copy of such press release is being furnished as Exhibit 99.1 to this report. The information, including Exhibit 99.1, in this Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall otherwise be expressly set forth by specific…2026-11-13SEC EDGAR 8-K 0001104659-26-126525 (text as filed, excerpt)2026-11-22 03:17 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-10-01)As previously disclosed, on July 25, 2024, Fortress Biotech, Inc. (the “Company”), as borrower, entered into a $50.0 million senior secured credit agreement (as amended on December 12, 2025 and February 22, 2026, the “Oaktree Agreement”) with Oaktree Fund Administration, LLC and the lenders from time-to-time party thereto. On September 30, 2026, the Company repaid in full the remaining $15.0 million in outstanding principal under the facility, together with approximately $435,000 in accrued interest, a prepayment fee of $150,000 and other closing costs. Upon such repayment, all indebtedness under the Oaktree Agreement was deemed satisfied and paid in full, all liens and other security…2026-10-01SEC EDGAR 8-K 0001104659-26-112845 (text as filed, excerpt)2026-11-22 03:17 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-13)On August 13, 2026, Fortress Biotech, Inc. issued a press release to provide a corporate update and to announce its financial results for the quarter ended June 30, 2026. A copy of such press release is being furnished as Exhibit 99.1 to this report. The information, including Exhibit 99.1, in this Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall otherwise be expressly set forth by specific…2026-08-13SEC EDGAR 8-K 0001104659-26-095931 (text as filed, excerpt)2026-11-22 03:17 UTCReport an error
Plan (pension, plan no. 001)FORTRESS BIOTECH INC 401K PLAN: 230 participants, assets $19,013,2252025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 03:17 UTCReport an error
Plan (welfare, plan no. 501)FORTRESS BIOTECH INC WRAP PLAN DOCUMENT: 80 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 03:17 UTCReport an error
Largest institutional holder #1 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$3,173,8412026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #2 (13F as filed): Opaleye Management Inc.$2,723,4002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #3 (13F as filed): MACKENZIE FINANCIAL CORP$1,700,3692026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #4 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$919,9442026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #5 (13F as filed): BlackRock, Inc.$687,8332026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #6 (13F as filed): TWO SIGMA INVESTMENTS, LP$654,1852026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #7 (13F as filed): BRIDGEWAY CAPITAL MANAGEMENT, LLC$542,7462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #8 (13F as filed): VANGUARD FIDUCIARY TRUST CO$509,0952026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #9 (13F as filed): HB Wealth Management, LLC$357,0262026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error
Largest institutional holder #10 (13F as filed): Kestra Advisory Services, LLC$355,6792026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:17 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.